Mitochondrial tumor suppressors

Mitochondria and Cancer

Volumn , Issue , 2009, Pages 151-162

  Baysal, Bora E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876544814     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-84835-8_9     Document Type: Chapter

References (53)

1. Alam, N. A., Barclay, E., Rowan, A. J., Tyrer, J. P., Calonje, E., Manek, S., Kelsell, D., Leigh, I., Olpin, S., and Tomlinson, I. P. 2005. Clinical features of multiple cutaneous and uterine leiomyomatosis: An underdiagnosed tumor syndrome. Arch. Dermatol. 141:199-206.
2. Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., Niccoli-Sire, P., Richard, S., Rohmer, V., Sadoul, J. L., Strompf, L., Schlumberger, M., Bertagna, X., Plouin, P. F., Jeunemaitre, X., and Gimenez-Roqueplo, A. P. 2005. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23:8812-8818.
3. Arias-Stella, J. and Valcarcel, J. 1976. Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance. Hum. Pathol. 7:361-373.
4. Astrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E., and Baysal, B. E. 2003. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: Evidence for an oxygen-sensing defect. Hum. Genet. 113:228-237.
5. Astuti, D., Latif, F., Dallol, A., Dahia, P. L., Douglas, F., George, E., Skoldberg, F., Husebye, E. S., Eng, C., and Maher, E. R. 2001. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69:49-54.
6. Barker, K. T., Bevan, S., Wang, R., Lu, Y. J., Flanagan, A. M., Bridge, J. A., Fisher, C., Finlayson, C. J., Shipley, J., and Houlston, R. S. 2002. Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br. J. Cancer 87:446-448.
7. Bayley, J. P., Devilee, P., and Taschner, P. E. 2005. The SDH mutation database: An online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med. Genet. 6:39.
8. Baysal, B. E. 2002. Hereditary paraganglioma targets diverse paraganglia. J. Med. Genet. 39:617-622.
9. Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., van der, M. A., Taschner, P. E., Rubinstein, W. S., Myers, E. N., Richard, C. W., III, Cornelisse, C. J., Devilee, P., and Devlin, B. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848-851.
10. Baysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., III, Myers, E. N., Ferrell, R. E., and Rubinstein, W. S. 2002. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J. Med. Genet. 39:178-183.
11. Bourgeron, T., Chretien, D., Poggi-Bach, J., Doonan, S., Rabier, D., Letouze, P., Munnich, A., Rotig, A., Landrieu, P., and Rustin, P. 1994. Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J. Clin. Invest. 93:2514-2518.
12. Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Pequignot, E., Munnich, A., and Rotig, A. 1995. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat. Genet. 11:144-149.
13. Brandon, M., Baldi, P., and Wallace, D. C. 2006. Mitochondrial mutations in cancer. Oncogene 25:4647-4662.
14. Brouwers, F. M., Eisenhofer, G., Tao, J. J., Kant, J. A., Adams, K. T., Linehan, W. M., and Pacak, K. 2006. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J. Clin. Endocrinol. Metab. 91:4505-4509.
15. Cecchini, G., Maklashina, E., Yankovskaya, V., Iverson, T. M., and Iwata, S. 2003. Variation in proton donor/acceptor pathways in succinate: quinone oxidoreductases. FEBS Lett. 545:31-38.
16. Coller, H. A., Khrapko, K., Bodyak, N. D., Nekhaeva, E., Herrero-Jimenez, P., and Thilly, W. G. 2001. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 28:147-150.
17. Dahia, P. L., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., Hodin, R., Heitritter, S., Moore, F., Dluhy, R., Sosa, J. A., Ocal, I. T., Benn, D. E., Marsh, D. J., Robinson, B. G., Schneider, K., Garber, J., Arum, S. M., Korbonits, M., Grossman, A., Pigny, P., Toledo, S. P., Nose, V., Li, C., and Stiles, C. D. 2005. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 1:72-80.
18. Gallardo, M. E., Moreno-Loshuertos, R., Lopez, C., Casqueiro, M., Silva, J., Bonilla, F., Rodriguez, D. C., and Enriquez, J. A. 2006. m.6267G > A: A recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors. Hum. Mutat. 27:575-582.
19. Gatenby, R. A. and Gillies, R. J. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4:891-899.
20. Gottlieb, E. and Tomlinson, I. P. 2005. Mitochondrial tumour suppressors: A genetic and biochemical update. Nat. Rev. Cancer 5:857-866.
21. Ishii, N., Fujii, M., Hartman, P. S., Tsuda, M., Yasuda, K., Senoo-Matsuda, N., Yanase, S., Ayusawa, D., and Suzuki, K. 1998. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394:694-697.
22. Kaelin, W. G. 2005. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74:115-128.
23. Kiuru, M. and Launonen, V. 2004. Hereditary leiomyomatosis and renal cell cancer (HLRCC). Curr. Mol. Med. 4:869-875.
24. Kiuru, M., Lehtonen, R., Arola, J., Salovaara, R., Jarvinen, H., Aittomaki, K., Sjoberg, J., Visakorpi, T., Knuutila, S., Isola, J., Delahunt, B., Herva, R., Launonen, V., Karhu, A., and Aaltonen, L. A. 2002. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res. 62:4554-4557.
25. Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, W. G., Jr., and Schlisio, S. 2005. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8:155-167.
26. Neumann, H. P., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., Januszewicz, A., Eng, C., Smith, W. M., Munk, R., Manz, T., Glaesker, S., Apel, T. W., Treier, M., Reineke, M., Walz, M. K., Hoang-Vu, C., Brauckhoff, M., Klein-Franke, A., Klose, P., Schmidt, H., Maier-Woelfle, M., Peczkowska, M., Szmigielski, C., and Eng, C. 2002. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346:1459-1466.
27. Neumann, H. P., Pawlu, C., Peczkowska, M., Bausch, B., McWhinney, S. R., Muresan, M., Buchta, M., Franke, G., Klisch, J., Bley, T. A., Hoegerle, S., Boedeker, C. C., Opocher, G., Schipper, J., Januszewicz, A., and Eng, C. 2004. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951.
28. Niemann, S. and Muller, U. 2000. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26:268-270.
29. Oyedotun, K. S., Sit, C. S., and Lemire, B. D. 2007. The Saccharomyces cerevisiae succinate dehydrogenase does not require heme for ubiquinone reduction. Biochim. Biophys. Acta 1767:1436-1445.
30. Parker, W. H. 2007. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil. Steril. 87:725-736.
31. Piruat, J. I., Pintado, C. O., Ortega-Saenz, P., Roche, M., and Lopez-Barneo, J. 2004. The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia. Mol. Cell Biol. 24:10933-10940.
32. Pollard, P. J., Briere, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., Hargreaves, I. P., Heales, S. J., Chung, Y. L., Griffiths, J. R., Dalgleish, A., McGrath, J. A., Gleeson, M. J., Hodgson, S. V., Poulsom, R., Rustin, P., and Tomlinson, I. P. 2005. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14:2231-2239.
33. Pollard, P. J., Spencer-Dene, B., Shukla, D., Howarth, K., Nye, E., El Bahrawy, M., Deheragoda, M., Joannou, M., McDonald, S., Martin, A., Igarashi, P., Varsani-Brown, S., Rosewell, I., Poulsom, R., Maxwell, P., Stamp, G. W., and Tomlinson, I. P. 2007. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell 11:311-319.
34. Salas, A., Yao, Y. G., Macaulay, V., Vega, A., Carracedo, A., and Bandelt, H. J. 2005. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2:e296.
35. Saraste, M. 1999. Oxidative phosphorylation at the fin de siecle. Science 283:1488-1493.
36. Schiavi, F., Boedeker, C. C., Bausch, B., Peczkowska, M., Gomez, C. F., Strassburg, T., Pawlu, C., Buchta, M., Salzmann, M., Hoffmann, M. M., Berlis, A., Brink, I., Cybulla, M., Muresan, M., Walter, M. A., Forrer, F., Valimaki, M., Kawecki, A., Szutkowski, Z., Schipper, J., Walz, M. K., Pigny, P., Bauters, C., Willet-Brozick, J. E., Baysal, B. E., Januszewicz, A., Eng, C., Opocher, G., and Neumann, H. P. 2005. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057-2063.
37. Schofield, C. J. and Ratcliffe, P. J. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5:343-354.
38. Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., and Gottlieb, E. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77-85.
39. Shambaugh, G. E., III. 1977. Urea biosynthesis I. The urea cycle and relationships to the citric acid cycle. Am. J. Clin. Nutr. 30:2083-2087.
40. Smith, E. H., Janknecht, R., and Maher, L. J., III. 2007. Succinate inhibition of {alpha}-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Hum. Mol. Genet. 16:3136-3148.
41. Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., and Rao, Z. 2005. Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 121:1043-1057.
42. Suzuki, T., Sato, M., Yoshida, T., and Tuboi, S. 1989. Rat liver mitochondrial and cytosolic fumarases with identical amino acid sequences are encoded from a single gene. J. Biol. Chem. 264:2581-2586.
43. Szeto, S. S., Reinke, S. N., Sykes, B. D., and Lemire, B. D. 2007. Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate. J. Biol. Chem. 282:27518-27526.
44. Timmers, H. J., Kozupa, A., Eisenhofer, G., Raygada, M., Adams, K. T., Solis, D., Lenders, J. W., and Pacak, K. 2007. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J. Clin. Endocrinol. Metab. 92:779-786.
45. Tomlinson, I. P., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S., Roylance, R. R., Olpin, S., Bevan, S., Barker, K., Hearle, N., Houlston, R. S., Kiuru, M., Lehtonen, R., Karhu, A., Vilkki, S., Laiho, P., Eklund, C., Vierimaa, O., Aittomaki, K., Hietala, M., Sistonen, P., Paetau, A., Salovaara, R., Herva, R., Launonen, V., and Aaltonen, L. A. 2002. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30:406-410.
46. Tran, Q. M., Rothery, R. A., Maklashina, E., Cecchini, G., and Weiner, J. H. 2007. Escherichia coli succinate dehydrogenase variant lacking the heme b. Proc. Natl. Acad. Sci. USA 104:18007-18012.
47. Vanharanta, S., Pollard, P. J., Lehtonen, H. J., Laiho, P., Sjoberg, J., Leminen, A., Aittomaki, K., Arola, J., Kruhoffer, M., Orntoft, T. F., Tomlinson, I. P., Kiuru, M., Arango, D., and Aaltonen, L. A. 2006. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum. Mol. Genet. 15:97-103.
48. Yankovskaya, V., Horsefield, R., Tornroth, S., Luna-Chavez, C., Miyoshi, H., Leger, C., Byrne, B., Cecchini, G., and Iwata, S. 2003. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299:700-704.
49. Van der Mey, A. G., Maaswinkel-Mooy, P. D., Cornelisse, C. J., Schmidt, P. H., and van de Kamp, J. J. 1989. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 2:1291-1294.
50. Wallace, D. C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39:359-407.
51. Warburg, O. 1956. On the origin of cancer cells. Science 123:309-314.
52. Wei, M. H., Toure, O., Glenn, G. M., Pithukpakorn, M., Neckers, L., Stolle, C., Choyke, P., Grubb, R., Middelton, L., Turner, M. L., Walther, M. M., Merino, M. J., Zbar, B., Linehan, W. M., and Toro, J. R. 2006. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J. Med. Genet. 43:18-27.
53. Zanssen, S., and Schon, E. A. 2005. Mitochondrial DNA mutations in cancer. PLoS Medicine, 2:e401.